Skip to NavigationSkip to content

Laura Steele appointed President and General Manager for Lilly UK

Published on: 25/08/21

Eli Lilly and Company have announced that Laura Steele has been appointed President and General Manager (GM) for UK, Ireland & Northern Europe. Laura succeeds Ashley Diaz-Granados, who assumes a senior role within Lilly USA leading the company’s Immunology division.

Laura will lead Lilly’s commercial business operations in six countries, across the company’s current and emerging portfolio in Diabetes, Oncology, Immunology, and Neuroscience.

Steele said: “As we emerge from the COVID-19 pandemic, we must build on what we have learned during this crisis. From accelerating the set-up of new clinical trials to advances in delivering care outside of traditional settings, and combating health inequalities, the partnership and advances in care created during the pandemic must not be lost.”

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches